EPIT2

So what’s the difference?

The first serious consideration of section 7(4) of the Patents Act 1990 relating to innovative step, the decision of Gyles J in Delnorth Pty Ltd v Dura-Post (Aust) Pty Ltd [2008] FCA 1225, gives a somewhat unexpected interpretation of the phrase “substantial contribution to the working of the invention”. Gyles J commences with a concise [...]

Click here to see the full post
Life-Sciences

Gyles J Takes Aim at Enabling Disclosure

In Apotex Pty Ltd (formerly GenRx Pty Ltd) v Sanofi-Aventis [2008] FCA 1194, previously mentioned here, Gyles J concluded his consideration of novelty with the comment that: Anticipation is deadly but requires the accuracy of a sniper, not the firing of a 12 gauge shotgun. However his Honour’s findings on novelty, and in particular the [...]

Click here to see the full post
Designs

Two Wrongs Don’t make a Right but Two Countries make an International Exhibition

The Full Federal Court has allowed the appeal in Chiropedic Bedding Pty Ltd v Radburg Pty Ltd [2008] FCAFC 142, overturning the decision of the trial judge and holding that a furniture fair involving 250 Australian exhibitors and seven from New Zealand was an “international exhibition”. Section 47(1) provides that the fact that a design, [...]

Click here to see the full post
Life-Sciences

World’s Second Biggest Selling Drug Survives Revocation Suit

Apotex Pty Ltd (formerly GenRx Pty Ltd) v Sanofi-Aventis [2008] FCA 1194, handed down on Tuesday, determined a validity challenge to the Sanofi-Aventis patent covering the drug Clopidogrel, marketed as Plavix, the second highest selling pharmaceutical worldwide. While claims 1, 10 and 11 were found lacking novelty and claims 6 to 9 lacking inventive step, [...]

Click here to see the full post
Trademarks

Australian Courts and Spanish Law

In an appeal from a Trade Mark opposition, Ryan J in Neumann v Sons of the Desert SL [2008] FCA 1183, has seemingly significantly broadened the operation of section 42 of the Trade Marks Act. Section 42(b) provides that an application for the registration of a trade mark must be rejected if its use would [...]

Click here to see the full post
Life-Sciences

Requesting Patent Foreign Filing Permits – Section 25(5) by e-mail

Where a NZ resident wishes to file an application for a patent abroad without first filing a corresponding patent application in New Zealand, the resident must obtain a foreign filing permit from the Commissioner under section 25(5) before making the foreign patent application. IPONZ will now accept requests for foreign filing permit by email. The [...]

Click here to see the full post